Decision expected on drug for Kilkenny campaigners living with Freidrich’s Ataxia


Emily Felix and David McInerney are calling for funding for Skyclarys
Kilkenny campaigners are waiting on a final decision on Skyclarys, a drug which can slow the progress of Freidrich’s Ataxia (FA).
Campaigner Emily Felix recently appeared on national television and called on the government to fund Skyclarys. Emily and fellow campaigner, David McInerney, also from Kilkenny recently travelled to to the Dáil and pleaded with the Minister for Health, Jennifer Carroll MacNeill to fund the drug.
Skyclarys (omaveloxolone) is the only approved drug for FA and can slow the progress of symptoms by up to 50%. The drug is been reimbursed in several European countries including Germany, France, Spain, Italy, Czech Republic and Cyprus.
“I have spoken to quite a few people in these European countries with FA (who are using Skyclarys) and they have told me how their condition has stopped progressing,” said Emily.
The National Centre for Pharmacoeconomics (NCPE) has recommended against reimbursing the drug but the Government can go against this decision.
The pharmaceutical company, Biogen, who manufacture the drug is to submit a commercial proposal to the HSE Drugs Group before a recommendation is made to the HSE senior leadership team.
Approximately 200 people in Ireland have FA.
Deputy John McGuinness is calling on the government to fund the drug.
"The drug would help slow down the progression of this deadly disease. The government must fund this drug now given the positive impact it has on FA patients.
"It is morally and politically wrong people should be allowed to suffer when this drug is available.
“Approval and funding should be made available as matter of urgency.”